IDH1 and astrocytoma (excluding glioblastoma): By contrast, retained nuclear ATRX positivity in an IDH-mutant glioma should prompt analysis for 1p/19q codeletion in order to distinguish IDH-mutant astrocytoma from IDH-mutant and 1p/19q-codeleted oligodendroglioma.